Company Filing History:
Years Active: 2019-2024
Title: Zhenya Ni: Innovator in Engineered CD16 Technologies
Introduction
Zhenya Ni is a prominent inventor based in Edina, MN (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered CD16 technologies. With a total of 3 patents to her name, Zhenya is recognized for her innovative approaches to enhancing anti-tumor and anti-viral activities.
Latest Patents
Zhenya Ni's latest patents focus on polypeptides, cells, and methods involving engineered CD16. These disclosures describe a modified form of CD16 and genetically-modified cells that express this modified CD16. The modified form of CD16 is designed to exhibit increased anti-tumor and/or anti-viral activity, primarily due to its reduced susceptibility to ADAM17-mediated shedding upon NK cell stimulation. This advancement holds promise for improving therapeutic strategies in cancer and viral infections.
Career Highlights
Zhenya Ni is affiliated with the University of Minnesota, where she continues her research and development efforts. Her work has garnered attention for its potential applications in medical science and therapeutic interventions.
Collaborations
Zhenya collaborates with notable colleagues, including Bruce Kenneth Walcheck and Dan Samuel Kaufman. Their combined expertise enhances the research initiatives at the University of Minnesota.
Conclusion
Zhenya Ni's innovative work in engineered CD16 technologies exemplifies her commitment to advancing biotechnology. Her contributions are paving the way for new therapeutic approaches in combating diseases.